Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrifast Regulatory News (TRI)

Share Price Information for Trifast (TRI)

Share Price is delayed by 15 minutes
Get Live Data
66.00    0.00 (0.00%)
Bid:
65.20
Ask:
70.00
Spread: 4.80 (7.362%)
Market Cap: £89.08m
TRI Live PriceLast checked at - London Stock Exchange

Intraday Trifast Share Chart

Director/PDMRs share purchases

11 Apr 2025 07:00

RNS Number : 6026E
Trifast PLC
11 April 2025
 

 

 

Friday, 11 April 2025

 

 

Trifast plc

(the "Company")

 

 

Director/PDMR shareholdings

 

 

The Company has been notified of the following share purchase transactions by members of its leadership team:

 

Ø On Thursday 10 April, Mr. Clive Watson, Senior Independent Non-Executive Director, purchased a total of 20,000 ordinary shares of 5 pence each in the Company ("Ordinary Shares"). Following this transaction, and together with an additional 982 shares purchased through the Dividend Re-Investment Plan on 14 October 2024, Mr. Watson has a beneficial interest of 113,957 Ordinary Shares in the Company.

 

Ø On Wednesday 9 April, Ms Serena Lang, Independent Non-Executive Chair, purchased a total of 15,726 ordinary shares of 5 pence each in the Company ("Ordinary Shares"). Following this transaction, Ms. Lang has a beneficial interest of 187,011 Ordinary Shares in the Company.

 

Ø On Wednesday 9 April, Mr. Daniel Jack, Chief Commercial Officer & Managing Director, UK & Ireland, and a member of the Executive Leadership Team, purchased a total of 17,506 ordinary shares of 5 pence each in the Company ("Ordinary Shares") Following this transaction, Mr. Jack has a beneficial interest of 35,986 Ordinary Shares in the Company.

 

The notifications below are made in accordance with the requirements of the EU Market Abuse Regulation.

 

 

Enquiries:

Trifast plc

Christopher Morgan

Company Secretary

Tel: +44 (0) 1825 769696

www.trifast.com

 

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Clive Watson

2.

Reason for the notification

a.

Position/status

Independent Non-Executive Director

b.

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Trifast plc

b.

LEI

213800WFIVE6RWK3CR22

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 5 pence each 

GB0008883927

b.

Nature of the transaction

Purchase of shares

c.

Price(s) and volume(s)

Price(s)

Volume(s)

61.8785p

20,000

d.

Aggregated information

· Aggregated volume

· Price

 

20,000

61,8785p

e.

Date of the transaction

10 April 2025

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Clive Watson

2.

Reason for the notification

a.

Position/status

Independent Non-Executive Director

b.

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Trifast plc

b.

LEI

213800WFIVE6RWK3CR22

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 5 pence each 

GB0008883927

b.

Nature of the transaction

Purchase of shares through the Dividend Re-Investment Plan

c.

Price(s) and volume(s)

 

Price(s)

Volume(s)

79.558p

982

d.

Aggregated information

· Aggregated volume

· Price

 

982

79.558p

e.

Date of the transaction

14 October 2024

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Serena Lang

2.

Reason for the notification

a.

Position/status

Independent Non-Executive Chair

b.

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Trifast plc

b.

LEI

213800WFIVE6RWK3CR22

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 5 pence each 

GB0008883927

b.

Nature of the transaction

Purchase of shares

c.

Price(s) and volume(s)

 

Price(s)

Volume(s)

58.6200p

15,726

d.

Aggregated information

· Aggregated volume

· Price

 

15,726

58.6200p

e.

Date of the transaction

9 April 2025

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Daniel Jack

2.

Reason for the notification

a.

Position/status

Chief Commercial Officer & Managing Director, UK & Ireland

b.

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Trifast plc

b.

LEI

213800WFIVE6RWK3CR22

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 5 pence each 

GB0008883927

b.

Nature of the transaction

Purchase of shares

c.

Price(s) and volume(s)

Price(s)

Volume(s)

58.938p

5,044

59.1300p

12,462

d.

Aggregated information

· Aggregated volume

· Price

 

17,506

58.3628p

e.

Date of the transaction

9 April 2025

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHURRURVWUSAUR
Date   Source Headline
3rd Jun 20267:46 amRNSDirector Declaration
5th May 20261:03 pmRNSHolding(s) in Company
29th Apr 20267:00 amRNSTrading Statement
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20261:44 pmRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSHolding(s) in Company
27th Mar 20262:53 pmRNSHolding(s) in Company
27th Mar 20262:43 pmRNSDirector/PDMR Shareholding
17th Feb 20261:15 pmRNSDirector/PDMR Shareholding
16th Feb 20263:02 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSTrading Statement
19th Jan 20268:34 amRNSDirector Declaration
9th Jan 202611:02 amRNSDirector/PDMR Shareholding
23rd Dec 202512:35 pmRNSHolding(s) in Company
23rd Dec 202512:35 pmRNSHolding(s) in Company
23rd Dec 202512:35 pmRNSHolding(s) in Company
18th Nov 20257:00 amRNSHalf-year Financial Report
23rd Oct 20255:10 pmRNSDirector/PDMR Shareholding
21st Oct 20257:00 amRNSTrading Statement
15th Oct 20253:06 pmRNSDirector/PDMR Shareholding
7th Oct 20259:01 amRNSDirector/PDMR Shareholding
12th Sep 20257:00 amRNSBoard Fellow Appointment
11th Sep 20251:31 pmRNSResult of AGM
11th Sep 20257:00 amRNSTrading Statement
5th Sep 20253:00 pmRNSDirector/PDMR Shareholding
18th Aug 20251:21 pmRNSDirector/PDMR Shareholding
28th Jul 20253:19 pmRNSDirector/PDMR Shareholding
22nd Jul 20258:08 amRNSNotice of AGM
14th Jul 20251:44 pmRNSDirector/PDMR Shareholding - Replacement
14th Jul 20251:17 pmRNSDirector/PDMR Shareholding
10th Jul 20257:00 amRNSFinal Results
27th Jun 20252:50 pmRNSNotice of Results
4th Jun 20257:00 amRNSTotal Voting Rights
19th May 20255:02 pmRNSHolding(s) in Company
30th Apr 20257:00 amRNSTrading Update & Notice of FY25 Annual Results
16th Apr 20253:02 pmRNSShare purchases under Dividend Re-Investment Plan
11th Apr 20257:00 amRNSDirector/PDMRs share purchases
2nd Apr 20251:25 pmRNSBlock listing Interim Review
27th Mar 20252:15 pmRNSDirector/PDMR Shareholding
24th Mar 202512:12 pmRNSDirector/PDMR Shareholding - Purchase of Shares
13th Feb 20257:00 amRNSTrading update
5th Feb 202511:19 amRNSDirector/PDMR Shareholding
4th Feb 20253:54 pmRNSDirector/PDMR Shareholding
28th Jan 20252:07 pmRNSDirector/PDMR Shareholding
27th Jan 20255:15 pmRNSDirector/PDMR Shareholding
23rd Jan 20255:27 pmRNSHolding(s) in Company
11th Dec 20241:58 pmRNSHolding(s) in Company
11th Dec 20241:55 pmRNSDirector/PDMR Shareholding
10th Dec 20243:23 pmRNSTotal Voting Rights
29th Nov 202411:15 amRNSChange of Auditor & Registered office address

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.